datelliptium chloride has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azab, M; Borel, C; Bouloux, C; Khayat, D; Malaurie, E; Paraisot, D; Weil, M | 1 |
1 trial(s) available for datelliptium chloride and Neoplasms
| Article | Year |
|---|---|
Phase I study of Datelliptium chloride, hydrochloride given by 24-h continuous intravenous infusion.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Ellipticines; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms | 1992 |